Key result
Doxorubicin chemotherapy is linked to an ~11% decline in RV function measured by TAPSE.
Why the study?
Anthracycline chemotherapy is known for dose-dependent cardiotoxicity primarily affecting the left ventricle, but its impact on right ventricular function assessed by TAPSE is less understood.
Does doxorubicin chemotherapy reduce TAPSE and LVEF in adult cancer patients?
Observational (n=74)
No
Does doxorubicin chemotherapy reduce TAPSE and LVEF in adult cancer patients?
Doxorubicin chemotherapy causes significant right ventricular dysfunction as measured by TAPSE, which correlates with left ventricular dysfunction, emphasizing the importance of biventricular echocardiographic monitoring in cardio-oncology.
Answers are grounded in this paper and cite their sources.
Doxorubicin-associated TAPSE decline supports RV monitoring alongside LVEF; extends LV cardiotoxicity data but remains hypothesis-generating.
Introduction: Anthracycline-based chemotherapy is effective in treating various cancers but is known for dose-dependent cardiotoxicity, typically affecting the left ventricle (LV). Recent studies have suggested that the right ventricle (RV) may also be impacted. Tricuspid Annular Plane Systolic Excursion (TAPSE) is a non-invasive echocardiographic tool that assesses RV systolic function. This study aims to evaluate the effects of anthracycline chemotherapy on TAPSE and explore its correlation with LV ejection fraction (LVEF). Aim: To investigate the impact of anthracycline chemotherapy on RV function using TAPSE and to assess the relationship between changes in TAPSE and LVEF in cancer patients. Methods: This pre-post observational study included 74 cancer patients receiving anthracycline-based chemotherapy, specifically, Doxorubicin, at Wahidin Sudirohusodo General Hospital. Echocardiographic measurements of TAPSE and LVEF were performed before and after chemotherapy. Statistical analyses included Mann–Whitney, Wilcoxon signed-rank, and Kruskal–Wallis tests to evaluate changes in TAPSE and LVEF. Results: After chemotherapy, 79.7% of patients showed a significant decrease in TAPSE (mean reduction: 2.2 mm, p = 0.001). TAPSE decreased from 20.8 ± 2.3 mm pre-treatment to 18.6 ± 2.7 mm post-treatment. A significant positive correlation was found between changes in TAPSE and LVEF (r = 0.62, p = 0.001). Conclusions: Anthracycline chemotherapy leads to significant RV dysfunction, as indicated by reduced TAPSE, which correlates with LV dysfunction. TAPSE is a valuable tool for early detection of biventricular cardiotoxicity in cancer patients undergoing anthracycline treatment.
No takes yet. Share an insight, caveat, or question.
Saga et al. (2026) conducted an observational in Cancer (n=74). Doxorubicin chemotherapy vs. Pre-treatment baseline was evaluated on Tricuspid Annular Plane Systolic Excursion (TAPSE) (mean reduction: 2.2 mm, p=0.001). Doxorubicin chemotherapy reduced right ventricular systolic function, with mean TAPSE decreasing from 20.8 mm to 18.6 mm.
Synapse has enriched 10 related papers. Consider them for comparative context: